Can a TB infection leave a mark on the placenta?
NCT ID NCT06352970
First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
Researchers in Ethiopia are studying whether tuberculosis infection changes how the placenta develops and works. They will enroll 500 pregnant women at delivery clinics and use a blood test to identify those with TB infection. The team will compare placental tissue and infant outcomes between women with and without TB infection. The goal is to learn whether TB infection may contribute to pregnancy-related disorders through its effects on the placenta.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If TB infection harms the placenta, this could point to ways to protect pregnant women and their babies from pregnancy complications.
- What could go wrong
- This is an observational study, so it can show links but not prove cause and effect. Results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2024
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pregnant women with incipient delivery
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women admitted for delivery to study sites * Written informed consent * Age 18 years or greater Exclusion Criteria: * Chronic comorbidities (other than TB, HIV or pregnancy-related disorder) * Twin pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Placenta diseases are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Gandhi Memorial Hospital
RECRUITINGAddis Ababa, Ethiopia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- An open-label, randomized controlled trial of the new one-month regimen versus the current three-month regimen for the treatment of tuberculosis infection in vietnam
- Can a newer hepatitis b drug protect babies while being gentler on their bones?
- Can virtual mindfulness groups support pregnant individuals at risk?
- Can surveillance catch birth defects early in HIV-Affected pregnancies?
- Could a smartphone program ease pregnancy stress?
- Could a simple supplement boost pregnancy outcomes in botswana?